Friday, 10 May 2013

Gabon Pharmaceuticals and Healthcare Report Q3 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed
Gabon Pharmaceuticals and Healthcare Report Q3 2013
May 8th 2013, 00:00

BMI View: Increased longevity in developed markets translates into an increased demand for care for theelderly, healthcare services and medicines. However, despite increased life expectancy, in emergingmarkets such as Gabon communicable diseases will remain a significant health burden over the next twodecades. This will continue to limit revenue-earning opportunities for companies whose product portfolioscontain treatments for long-term diseases.Headline Expenditure Forecasts? Pharmaceuticals: XAF67.65bn (US$136mn) in 2012 to XAF72.45bn (US$148mn) in 2013; +7.1% inlocal currency and 9.0% in US dollar terms.? Healthcare: XAF278.54bn (US$559mn) in 2012 to XAF2...

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment